Kendall Capital Management »

Biosante Pharmaceuticals shares owned by Kendall Capital Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Kendall Capital Management from 13F filings

Historical chart of Kendall Capital Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Kendall Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Kendall Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $612k 7.4k 82.78

More positions owned by Kendall Capital Management

T. Rowe Price Small-Mid Cap ETF Small Mid Cap (TMSL)
JPMorgan International Research Enhanced Equity ETF Intrnl Res Eqt (JIRE)
Fidelity Enhanced Mid Cap ETF Enh Mid Cor Etf (FMDE)
Dell Technologies CL C (DELL)
Broadcom (AVGO)
Vanguard Growth Index Fund ETF Growth Etf (VUG)
KLA Corp Com New (KLAC)
Avnet (AVT)
Vanguard Emerging Markets Stock ETF Ftse Emr Mkt Etf (VWO)
JPMorgan Ultra-Short Income ETF Ultra Shrt Etf (JPST)
Hewlett Packard Enterprise (HPE)
Omni (OMC)
ACM Research Com Cl A (ACMR)
Vanguard Large-Cap ETF Large Cap Etf (VV)
Apple (AAPL)

View all positions for Kendall Capital Management

Top funds holding Biosante Pharmaceuticals

BlackRock
Soleus Capital Management
Vanguard Capital Management
State Street Corporation
Tang Capital Management
Dimensional Fund Advisors
American Century Companies
Arrowstreet Capital, Limited Partnership
Global Alpha Capital Management
Geode Capital Management
Millennium Management
Nuveen
Vanguard Portfolio Management
Ranger Investment Management
Deutsche Bank Aktiengesellschaft

View all funds holding Biosante Pharmaceuticals